Clinical Trials · NCT04390646

GnRH Therapy on Cognition in Down Syndrome

Name: GnRH Therapy on Cognition in Down Syndrome
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 2/Phase 3Gonadorelin

Phase: Phase 2/Phase 3
Recruitment status: Recruiting
Sponsor: Nelly Pitteloud
Enrollment: 56
Start date: Aug 2020
Locations: 1 site, Switzerland
Primary endpoint: Cognition

View Gonadorelin compound reference